Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers
Bingnan Zhang, Kavya Ramkumar, Robert J. Cardnell, et al.
British Journal of Cancer (2021) Vol. 125, Iss. 10, pp. 1333-1340
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

PARP inhibitors: enhancing efficacy through rational combinations
Deepak Bhamidipati, Jaime Haro-Silerio, Timothy A. Yap, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 6, pp. 904-916
Open Access | Times Cited: 75
Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma
Chenhao Zhou, Jialei Weng, Chunxiao Liu, et al.
Gastroenterology (2023) Vol. 164, Iss. 7, pp. 1261-1278
Closed Access | Times Cited: 65
Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control
Kyle Concannon, Benjamin B. Morris, Carl M. Gay, et al.
Molecular Cell (2023) Vol. 83, Iss. 5, pp. 660-680
Open Access | Times Cited: 28
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)
Matthew Ingham, Jacob B. Allred, Li Chen, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 25, pp. 4154-4163
Closed Access | Times Cited: 25
Structural, molecular, and functional insights into Schlafen proteins
Ukhyun Jo, Yves Pommier
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 6, pp. 730-738
Open Access | Times Cited: 38
TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor
Ukhyun Jo, Yasuhisa Murai, Keli Agama, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 7, pp. 1090-1102
Open Access | Times Cited: 30
Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer
Anna Keogh, Stephen P. Finn, Teodora Radonic
Cancers (2022) Vol. 14, Iss. 15, pp. 3772-3772
Open Access | Times Cited: 28
Reconsidering the mechanisms of action of PARP inhibitors based on clinical outcomes
Hiroshi Onji, Junko Murai
Cancer Science (2022) Vol. 113, Iss. 9, pp. 2943-2951
Open Access | Times Cited: 23
The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancer
Daniela Scattolin, Alessandro Dal Maso, Alessandra Ferro, et al.
Cancer Treatment Reviews (2024) Vol. 128, pp. 102768-102768
Closed Access | Times Cited: 6
Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through single-strand DNA gap accumulation behind replication forks
Hiroshi Onji, Sota Tate, Tomohisa Sakaue, et al.
Oncogene (2024) Vol. 43, Iss. 32, pp. 2475-2489
Open Access | Times Cited: 5
Precision Oncology with Drugs Targeting the Replication Stress, ATR, and Schlafen 11
Ukhyun Jo, Yasuhisa Murai, Naoko Takebe, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4601-4601
Open Access | Times Cited: 32
SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer
Kiran Kundu, Robert J. Cardnell, Bingnan Zhang, et al.
Translational Lung Cancer Research (2021) Vol. 10, Iss. 11, pp. 4095-4105
Open Access | Times Cited: 29
Correlation of Systemic Inflammation Parameters and Serum SLFN11 in Small Cell Lung Cancer—A Prospective Pilot Study
I. Simic, Azra Guzonjić, Jelena Kotur Stevuljević, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 976-976
Open Access | Times Cited: 4
Schlafens: Emerging Therapeutic Targets
Ricardo E. Perez, Frank Eckerdt, Leonidas C. Platanias
Cancers (2024) Vol. 16, Iss. 10, pp. 1805-1805
Open Access | Times Cited: 4
Immunotherapy in Extensive-Stage Small Cell Lung Cancer
Rola El Sayed, Normand Blais
Current Oncology (2021) Vol. 28, Iss. 5, pp. 4093-4108
Open Access | Times Cited: 27
Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer
Bingnan Zhang, C. Allison Stewart, Qi Wang, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 3, pp. 569-576
Open Access | Times Cited: 19
SLFN11-mediated tRNA regulation induces cell death by disrupting proteostasis in response to DNA-damaging agents
Yuki Iimori, Teppei Morita, Takeshi Masuda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrence
Muthana Al Abo, Wen-Chi Foo, Lauren E. Howard, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer
Danielle Smith, Sapna Lunj, Antony Adamson, et al.
Nature Reviews Urology (2024)
Closed Access | Times Cited: 3
Mouse Slfn8 and Slfn9 genes complement human cells lacking SLFN11 during the replication stress response
Erin Alvi, Ayako L. Mochizuki, Y Katsuki, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 8
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients
Prajwol Shrestha, Steven Kao, Veronica Cheung, et al.
Molecular Oncology (2024)
Open Access | Times Cited: 2
Therapeutic Targeting of DNA Repair Pathways in Pediatric Extracranial Solid Tumors: Current State and Implications for Immunotherapy
Sophia Zhao, Daniel Prior, Christine M. Heske, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1648-1648
Open Access | Times Cited: 2
Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer
Adva Kochavi, Remco Nagel, Pierre-René Körner, et al.
Nucleic Acids Research (2024)
Open Access | Times Cited: 1
Conventional chemotherapy: millions of cures, unresolved therapeutic index
Anthony Letai, Hugues de Thé
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 1
Study of Clinical Predictive Value and Immune Characterization of SLFN11 in Clear Cell Renal Cell Carcinoma
Yifu Liu, Zhicheng Zhang, Shengqiang Fu, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 6741-6754
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top